| Entry |
|
|---|
| Name |
Amsacrine;
mAMSA;
4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide
|
|---|
| Formula |
C21H19N3O3S
|
|---|
| Exact mass |
393.1147
|
|---|
| Mol weight |
393.46
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX01 Amsacrine
D02321 Amsacrine (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01529 Topoisomerase inhibitor
DG01527 Topoisomerase II inhibitor
D02321 Amsacrine
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
DNA topoisomerase
TOP2
D02321 Amsacrine (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 28
1 C8x C 31.7100 -27.7200
2 C8x C 31.7100 -29.1200
3 C8x C 32.9000 -29.8200
4 C8y C 34.1600 -29.1200
5 C8y C 34.1600 -27.7200
6 C8x C 32.9000 -27.0200
7 N5x N 35.3500 -29.8200
8 C8y C 36.5400 -29.1200
9 C8y C 36.5400 -27.7200
10 C8y C 35.3500 -27.0200
11 C8x C 37.8000 -29.8200
12 C8x C 38.9900 -29.1200
13 C8x C 38.9900 -27.7200
14 C8x C 37.8000 -27.0200
15 N1b N 35.3500 -25.6200
16 C8y C 36.5400 -24.9200
17 C8x C 37.7300 -25.6200
18 C8x C 38.9900 -24.9200
19 C8y C 38.9900 -23.5200
20 C8x C 37.8000 -22.8200
21 C8y C 36.5400 -23.5200
22 O2a O 35.3500 -22.8200
23 C1a C 34.1600 -23.5200
24 N1b N 40.1800 -22.8200
25 S4a S 41.5800 -22.8200
26 C1a C 42.9800 -22.8200
27 O3c O 41.5800 -24.2200
28 O3c O 41.5800 -21.4200
BOND 31
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 8 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 9 14 1
17 10 15 1
18 15 16 1
19 16 17 2
20 17 18 1
21 18 19 2
22 19 20 1
23 20 21 2
24 16 21 1
25 21 22 1
26 22 23 1
27 19 24 1
28 24 25 1
29 25 26 1
30 25 27 2
31 25 28 2
|
|---|
